Lymphovascular invasion is an independent prognostic factor for survival in pathologically proven N2 non-small cell lung cancer.
CONCLUSION: Lymphovascular invasion was identified as the only independent prognostic factor for 5-year overall survival and recurrence-free survival in our pathologically proven N2 NSCLC cohort when controlled for adjuvant therapy. This study extends the current evidence of an adverse prognostic effect of lymphovascular invasion on a stage III population, confirms the adverse prognostic effect of lymphovascular invasion detected by immunohistochemistry, and thereby reveals another subgroup within the pN2 population with worse prognosis regarding 5-year overall survival and recurrence-free survival.  .
PMID: 33577703 [PubMed - as supplied by publisher]
Source: Swiss Medical Weekly - Category: General Medicine Authors: Guglielmetti LC, Schneiter D, Hillinger S, Opitz I, Caviezel C, Weder W, Inci I Tags: Swiss Med Wkly Source Type: research
More News: Cancer | Cancer & Oncology | General Medicine | Lung Cancer | Non-Small Cell Lung Cancer | Study | Switzerland Health